Medicines may only be marketed in Belgium if they are authorised or registered. All authorised medicines are listed in the FAMHP's medicinal products database, which includes medicines for human and veterinary use.

Healthcare professionals must have access to objective, up-to-date and easily accessible information about medicines at all times. The FAMHP has partnered with the Belgian Centre for Pharmacotherapeutic Information (BCFI/CBIP), which is subsidised by the FAMHP.

A directory has been published on the BCFI's website, in which healthcare professionals can access all important information about medicines.

The FAMHP has developed an application to communicate about the availability of medicines: PharmaStatus.

The medicinal products database of the Federal Agency for Medicines and Health Products (FAMHP) contains all medicines for human and veterinary use that have a valid marketing authorisation, registration, parallel import authorisation or a temporary use authorisation in Belgium. The database also includes, in a separate section, the medicines whose authorisation have been suspended or withdrawn since 1 January 2019.

The consumption of antimicrobial medicines has risen sharply in recent decades, both in humans and animals. Antibiotics in particular, but also antiviral, antifungal and antiparasitic medicines, belong to the category of antimicrobial medicines. The frequent use of antimicrobial medicines has caused microbes to become increasingly resistant to these medicines. This is known as antimicrobial resistance or AMR.